Las Vegas, NV – November 01, 2014 — (TechSonian) – AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to cell cycle dysregulation, endoplasmic reticulum stress, neurodegeneration and apoptosis, will be hosting the 3rd Alzheimer’s-Focused #C4CT Summit powered by MDM international at the United Nations.